MAINTENANCE OF RESPONSE TO BIMEKIZUMAB OVER 3 YEARS OF TREATMENT IN PATIENTS WITH ACTIVE ANKYLOSING SPONDYLITIS: POST HOC ANALYSES FROM THE BE AGILE STUDY AND ITS OPEN-LABEL EXTENSION
Navarro-Compan V, Rudwaleit M, De Peyrecave N, Fleurinck C, Oortgiesen M, Taieb V, Baraliakos X (2022)
Annals of the Rheumatic Diseases 81(Suppl. 1): 771-772.
Kurzbeitrag Konferenz / Poster
| Veröffentlicht | Englisch
Download
Es wurden keine Dateien hochgeladen. Nur Publikationsnachweis!
Autor*in
Navarro-Compan, V.;
Rudwaleit, MartinUniBi;
De Peyrecave, N.;
Fleurinck, C.;
Oortgiesen, M.;
Taieb, V.;
Baraliakos, X.
Einrichtung
Erscheinungsjahr
2022
Serien- oder Zeitschriftentitel
Annals of the Rheumatic Diseases
Band
81
Ausgabe
Suppl. 1
Seite(n)
771-772
ISSN
0003-4967
eISSN
1468-2060
Page URI
https://pub.uni-bielefeld.de/record/2966738
Zitieren
Navarro-Compan V, Rudwaleit M, De Peyrecave N, et al. MAINTENANCE OF RESPONSE TO BIMEKIZUMAB OVER 3 YEARS OF TREATMENT IN PATIENTS WITH ACTIVE ANKYLOSING SPONDYLITIS: POST HOC ANALYSES FROM THE BE AGILE STUDY AND ITS OPEN-LABEL EXTENSION. Annals of the Rheumatic Diseases. 2022;81(Suppl. 1):771-772.
Navarro-Compan, V., Rudwaleit, M., De Peyrecave, N., Fleurinck, C., Oortgiesen, M., Taieb, V., & Baraliakos, X. (2022). MAINTENANCE OF RESPONSE TO BIMEKIZUMAB OVER 3 YEARS OF TREATMENT IN PATIENTS WITH ACTIVE ANKYLOSING SPONDYLITIS: POST HOC ANALYSES FROM THE BE AGILE STUDY AND ITS OPEN-LABEL EXTENSION. Annals of the Rheumatic Diseases, 81(Suppl. 1), 771-772. https://doi.org/10.1136/annrheumdis-2022-eular.2138
Navarro-Compan, V., Rudwaleit, Martin, De Peyrecave, N., Fleurinck, C., Oortgiesen, M., Taieb, V., and Baraliakos, X. 2022. “MAINTENANCE OF RESPONSE TO BIMEKIZUMAB OVER 3 YEARS OF TREATMENT IN PATIENTS WITH ACTIVE ANKYLOSING SPONDYLITIS: POST HOC ANALYSES FROM THE BE AGILE STUDY AND ITS OPEN-LABEL EXTENSION”, Annals of the Rheumatic Diseases, 81 (Suppl. 1): 771-772.
Navarro-Compan, V., Rudwaleit, M., De Peyrecave, N., Fleurinck, C., Oortgiesen, M., Taieb, V., and Baraliakos, X. (2022). MAINTENANCE OF RESPONSE TO BIMEKIZUMAB OVER 3 YEARS OF TREATMENT IN PATIENTS WITH ACTIVE ANKYLOSING SPONDYLITIS: POST HOC ANALYSES FROM THE BE AGILE STUDY AND ITS OPEN-LABEL EXTENSION. Annals of the Rheumatic Diseases 81, 771-772.
Navarro-Compan, V., et al., 2022. MAINTENANCE OF RESPONSE TO BIMEKIZUMAB OVER 3 YEARS OF TREATMENT IN PATIENTS WITH ACTIVE ANKYLOSING SPONDYLITIS: POST HOC ANALYSES FROM THE BE AGILE STUDY AND ITS OPEN-LABEL EXTENSION. Annals of the Rheumatic Diseases, 81(Suppl. 1), p 771-772.
V. Navarro-Compan, et al., “MAINTENANCE OF RESPONSE TO BIMEKIZUMAB OVER 3 YEARS OF TREATMENT IN PATIENTS WITH ACTIVE ANKYLOSING SPONDYLITIS: POST HOC ANALYSES FROM THE BE AGILE STUDY AND ITS OPEN-LABEL EXTENSION”, Annals of the Rheumatic Diseases, vol. 81, 2022, pp. 771-772.
Navarro-Compan, V., Rudwaleit, M., De Peyrecave, N., Fleurinck, C., Oortgiesen, M., Taieb, V., Baraliakos, X.: MAINTENANCE OF RESPONSE TO BIMEKIZUMAB OVER 3 YEARS OF TREATMENT IN PATIENTS WITH ACTIVE ANKYLOSING SPONDYLITIS: POST HOC ANALYSES FROM THE BE AGILE STUDY AND ITS OPEN-LABEL EXTENSION. Annals of the Rheumatic Diseases. 81, 771-772 (2022).
Navarro-Compan, V., Rudwaleit, Martin, De Peyrecave, N., Fleurinck, C., Oortgiesen, M., Taieb, V., and Baraliakos, X. “MAINTENANCE OF RESPONSE TO BIMEKIZUMAB OVER 3 YEARS OF TREATMENT IN PATIENTS WITH ACTIVE ANKYLOSING SPONDYLITIS: POST HOC ANALYSES FROM THE BE AGILE STUDY AND ITS OPEN-LABEL EXTENSION”. Annals of the Rheumatic Diseases 81.Suppl. 1 (2022): 771-772.
Export
Markieren/ Markierung löschen
Markierte Publikationen
Web of Science
Dieser Datensatz im Web of Science®Suchen in
Google Scholar